A federal judge overseeing the Provigil antitrust litigation has awarded attorneys representing end-payers nearly $22 million in fees.

U.S. District Judge Mitchell Goldberg of the Eastern District of Pennsylvania awarded $21.9 million to lead plaintiffs attorneys, including Kevin Love of Criden & Love in South Miami, who represent consumers and companies that paid for the drug after Cephalon.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]